Select Region or Location
Americas
  • Argentina
  • Brazil
  • Canada
  • Mexico
  • United States
  • Other Americas
Europe
  • Austria
  • Belgium
  • Bulgaria
  • Croatia/Hrvatska
  • Cyprus
  • Czech Republic
  • Denmark
  • Estonia
  • Finland
  • France
  • Germany
  • Greece
  • Hungary
  • Ireland
  • Italy
  • Latvia
  • Liechtenstein
  • Lithuania
  • Luxembourg
  • Malta
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Romania
  • Slovak Republic
  • Slovenia
  • Spain
  • Sweden
  • Switzerland
  • Turkey
  • United Kingdom
  • Other Europe
Asia Pacific
  • Australia
  • China
  • India
  • Indonesia
  • Japan
  • Korea, Republic of
  • Malaysia
  • New Zealand
  • Philippines
  • Singapore
  • Thailand
  • Vietnam
  • Other Asia Pacific
Africa And Middle East
  • Egypt
  • Israel
  • Other Africa And Middle East
USD
Home Cart Sign in  
Chemical Structure| 2170606-74-1 Chemical Structure| 2170606-74-1

Structure of DB2313
CAS No.: 2170606-74-1

Chemical Structure| 2170606-74-1

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

DB2313 is a first-in-class potent small-molecule inhibitor of PU.1. DB2313 disrupts the interaction of PU.1 with target gene promoters and leads to down-regulation of canonical PU.1 transcriptional targets.

4.5 *For Research Use Only! Not for Human Use. We Do Not Sell to Patients.

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

DE Stock

US Stock

Asia Stock

Global Stock

In Stock
{[ item.pr_size ]}{[ size_append_text(item.pr_size, proInfo.prAm, 'list') ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

  • {[ item.pr_size ]}
    {[ size_append_text(item.pr_size, proInfo.prAm, 'list') ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of DB2313

CAS No. :2170606-74-1
Formula : C42H41FN8O2
M.W : 708.83
SMILES Code : FC=1C(=CC=CC1COC=2C=CC(=CC2)C3=NC4=CC=C(C=C4N3)C(=N)NC(C)C)COC=5C=CC(=CC5)C6=NC7=CC=C(C=C7N6)C(=N)NC(C)C
English Name :2,2'-((((2-Fluoro-1,3-phenylene)bis(methylene))bis(oxy))bis(4,1-phenylene))bis(N-isopropyl-1H-benzo[d]imidazole-6-carboximidamide)
MDL No. :N/A

Safety of DB2313

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
human monocyte-derived macrophages 0.5 μM 7 days Transdifferentiation of macrophages into neuronal cells, observed neuron-like morphology and expression of neuronal markers Front Cell Neurosci. 2023 Aug 11;17:1225504

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
BALB/c mice HDM-induced model of experimental asthma Intranasal administration 1 mg/kg and 8 mg/kg 5 days per week for 3 weeks DB2313 (8 mg/kg) decreased mucus secreting cell number, and DB2313 (1 mg/kg) reduced small airway collagen deposition. Both doses decreased airway hyperresponsiveness. Respir Res. 2023 Jan 25;24(1):32
BALB/c mice Subcutaneous xenograft model Intraperitoneal injection 10 mg/kg/day Once daily for 7 days DB2313 significantly inhibited tumor burden, increased FTO expression, and reduced Ki67 and CD44 expression Mol Ther Nucleic Acids. 2022 Jan 1;27:699-717

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

1.41mL

0.28mL

0.14mL

7.05mL

1.41mL

0.71mL

14.11mL

2.82mL

1.41mL

 

Historical Records

Categories